title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - C3.ai  ( NYSE:AI ) , Asset Entities  ( NASDAQ:ASST ) ",20241210T110529,https://www.benzinga.com/24/12/42408189/why-c3-ai-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket,PCSA,0.162802,Somewhat-Bullish,0.209914
"Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday - Constellation Brands  ( NYSE:STZ ) ",20241003T071046,https://www.benzinga.com/news/earnings/24/10/41158294/constellation-brands-levi-strauss-and-3-stocks-to-watch-heading-into-thursday,PCSA,0.379051,Bullish,0.554893
Nasdaq Down 1%; JetBlue Airways Shares Spike Higher - JetBlue Airways  ( NASDAQ:JBLU ) ,20240730T183101,https://www.benzinga.com/news/earnings/24/07/40047993/nasdaq-down-1-jetblue-airways-shares-spike-higher,PCSA,0.136113,Neutral,0.020588
Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results - Procter & Gamble  ( NYSE:PG ) ,20240730T161627,https://www.benzinga.com/news/earnings/24/07/40044855/crude-oil-down-1-procter-gamble-shares-fall-after-q4-results,PCSA,0.121959,Neutral,0.019413
Dow Jumps 200 Points; Pfizer Earnings Top Views - Pfizer  ( NYSE:PFE ) ,20240730T141254,https://www.benzinga.com/news/earnings/24/07/40039782/dow-jumps-200-points-pfizer-earnings-top-views,PCSA,0.1172,Neutral,0.019044
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer,20240611T122000,https://www.globenewswire.com/news-release/2024/06/11/2896777/0/en/Processa-Pharmaceuticals-Announces-Positive-Efficacy-Results-from-Preliminary-Evaluation-of-Phase-1b-Dose-escalating-Trial-with-NGC-Cap-in-Gastrointestinal-Cancer.html,PCSA,0.09439,Neutral,0.04277
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Alphabet  ( NASDAQ:GOOGL ) ,20240426T121832,https://www.benzinga.com/news/24/04/38458188/why-alphabet-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket,PCSA,0.197951,Neutral,-0.033421
"Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results - ATN International  ( NASDAQ:ATNI ) , Bristol-Myers Squibb  ( NYSE:BMY ) ",20240425T183233,https://www.benzinga.com/news/earnings/24/04/38441305/crude-oil-moves-higher-bristol-myers-squibb-shares-fall-after-q1-results,PCSA,0.121037,Somewhat-Bullish,0.173238
"S&P 500 Down Over 1%; Merck Increases 2024 Outlook - ATN International  ( NASDAQ:ATNI ) , Hertz Global Holdings  ( NASDAQ:HTZ ) ",20240425T160430,https://www.benzinga.com/news/earnings/24/04/38437240/s-p-500-down-over-1-merck-increases-2024-outlook,PCSA,0.127795,Somewhat-Bullish,0.177508
"Dow Dips Over 500 Points; US GDP Growth Misses Expectations - Barfresh Food Group  ( NASDAQ:BRFH ) , Chicken Soup for the Soul  ( NASDAQ:CSSE ) ",20240425T134704,https://www.benzinga.com/news/earnings/24/04/38432253/dow-dips-over-500-points-us-gdp-growth-misses-expectations,PCSA,0.146469,Somewhat-Bullish,0.190593
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference,20240328T121500,https://www.globenewswire.com/news-release/2024/03/28/2853979/0/en/Processa-Pharmaceuticals-to-Present-at-the-MedInvest-Biotech-and-Pharma-Investor-Conference.html,PCSA,0.2256,Neutral,-0.017836
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting,20240325T121500,https://www.globenewswire.com/news-release/2024/03/25/2851598/0/en/Processa-Pharmaceuticals-to-Present-Data-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html,PCSA,0.186259,Neutral,-0.058647
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference,20240221T131500,https://www.globenewswire.com/news-release/2024/02/21/2832738/0/en/Processa-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html,PCSA,0.234307,Neutral,-0.018354
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference,20240214T180000,https://www.globenewswire.com/news-release/2024/02/14/2829368/0/en/Processa-Pharmaceuticals-to-Present-at-The-Winter-Wrap-Up-MicroCap-Rodeo-Winter-2024-Virtual-Conference.html,PCSA,0.237358,Neutral,-0.022321
"Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying - Abeona Therapeutics  ( NASDAQ:ABEO ) , OPKO Health  ( NASDAQ:OPK ) ",20240208T144104,https://www.benzinga.com/trading-ideas/long-ideas/24/02/37009155/processa-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying,PCSA,0.560594,Bullish,0.399276
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule,20240206T133000,https://www.globenewswire.com/news-release/2024/02/06/2824321/0/en/Processa-Pharmaceuticals-Regains-Compliance-with-Nasdaq-Minimum-Bid-Price-Rule.html,PCSA,0.226301,Neutral,-0.007142
"Expensify And 3 Other Stocks Under $3 Insiders Are Buying - Expensify  ( NASDAQ:EXFY ) , Perspective Therapeutics  ( AMEX:CATX ) ",20240202T120911,https://www.benzinga.com/trading-ideas/long-ideas/24/02/36907167/expensify-and-3-other-stocks-under-3-insiders-are-buying,PCSA,0.398781,Bullish,0.351024
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering,20240201T212200,https://www.globenewswire.com/news-release/2024/02/01/2822471/0/en/Processa-Pharmaceuticals-Announces-Closing-of-7-0-Million-Public-Offering.html,PCSA,0.091335,Neutral,0.063751
"Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying - Processa Pharma  ( NASDAQ:PCSA ) , PaySign  ( NASDAQ:PAYS ) ",20240201T134254,https://www.benzinga.com/trading-ideas/long-ideas/24/02/36887261/relmada-therapeutics-and-2-other-penny-stocks-insiders-are-buying,PCSA,0.454714,Bullish,0.388829
"Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results - Colgate-Palmolive  ( NYSE:CL ) , AppFolio  ( NASDAQ:APPF ) ",20240126T193218,https://www.benzinga.com/news/earnings/24/01/36807767/nasdaq-down-over-50-points-colgate-palmolive-posts-upbeat-results,PCSA,0.130217,Neutral,-0.096264
"Crude Oil Down 1%; American Express Shares Rise After Q4 Results - American Express  ( NYSE:AXP ) , AppFolio  ( NASDAQ:APPF ) ",20240126T170026,https://www.benzinga.com/news/earnings/24/01/36805309/crude-oil-down-1-american-express-shares-rise-after-q4-results,PCSA,0.134214,Neutral,-0.097731
What's Going With Processa Pharmaceuticals Stock Today? - Processa Pharma  ( NASDAQ:PCSA ) ,20240126T161653,https://www.benzinga.com/general/biotech/24/01/36804201/whats-going-on-with-anti-cancer-focused-processa-pharmaceuticals-stock-today,PCSA,0.453501,Somewhat-Bullish,0.211673
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering - Processa Pharma  ( NASDAQ:PCSA ) ,20240126T140403,https://www.benzinga.com/pressreleases/24/01/g36801112/processa-pharmaceuticals-announces-pricing-of-7-0-million-public-offering,PCSA,0.084572,Neutral,0.063678
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering,20240126T140400,https://www.globenewswire.com/news-release/2024/01/26/2817975/0/en/Processa-Pharmaceuticals-Announces-Pricing-of-7-0-Million-Public-Offering.html,PCSA,0.087503,Neutral,0.068502
"Intel, Nvidia, AMD, Processa Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Intel  ( NASDAQ:INTC ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",20240126T021427,https://www.benzinga.com/markets/equities/24/01/36794916/intel-nvidia-amd-processa-pharmaceuticals-tesla-why-these-5-stocks-are-on-investors-radars-today,PCSA,0.109455,Neutral,0.05657
"Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings - American Superconductor  ( NASDAQ:AMSC ) , American Airlines Group  ( NASDAQ:AAL ) ",20240125T201818,https://www.benzinga.com/news/earnings/24/01/36789093/nasdaq-edges-lower-american-airlines-posts-upbeat-earnings,PCSA,0.12165,Somewhat-Bullish,0.24723
"Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results - Intelligent Bio Solutions  ( NASDAQ:INBS ) , Akoustis Technologies  ( NASDAQ:AKTS ) ",20240125T180822,https://www.benzinga.com/news/earnings/24/01/36786638/crude-oil-rises-2-tesla-shares-plunge-after-downbeat-results,PCSA,0.119235,Somewhat-Bullish,0.245173
Why Processa Pharmaceuticals Stock Is Soaring - Processa Pharma  ( NASDAQ:PCSA ) ,20240125T163218,https://www.benzinga.com/news/24/01/36784420/why-processa-pharmaceuticals-stock-is-soaring,PCSA,0.595343,Bullish,0.563225
"Dow Surges Over 100 Points; US GDP Growth Tops Estimates - Intelligent Bio Solutions  ( NASDAQ:INBS ) , Akoustis Technologies  ( NASDAQ:AKTS ) ",20240125T154228,https://www.benzinga.com/news/earnings/24/01/36783052/dow-surges-over-100-points-us-gdp-growth-tops-estimates,PCSA,0.156461,Somewhat-Bullish,0.281384
"US Stocks Higher; Nasdaq Jumps 100 Points - Nuvve Holding  ( NASDAQ:NVVE ) , Fisker  ( NYSE:FSR ) ",20240122T151514,https://www.benzinga.com/news/earnings/24/01/36717533/us-stocks-higher-nasdaq-jumps-100-points,PCSA,0.261117,Neutral,0.117635
"S&P 500 Gains 1%; State Street Reports Upbeat Earnings - C3is  ( NASDAQ:CISS ) , Anitra  ( AMEX:AZTR ) ",20240119T191704,https://www.benzinga.com/news/earnings/24/01/36700365/s-p-500-gains-1-state-street-reports-upbeat-earnings,PCSA,0.129168,Neutral,0.092305
"Dow Jumps 150 Points; US Consumer Sentiment Surges In January - Anitra  ( AMEX:AZTR ) , C3is  ( NASDAQ:CISS ) ",20240119T170111,https://www.benzinga.com/news/earnings/24/01/36698245/dow-jumps-150-points-us-consumer-sentiment-surges-in-january,PCSA,0.151539,Neutral,0.101454
Why Processa Pharmaceuticals  ( PCSA )  Stock Is Skyrocketing - Processa Pharma  ( NASDAQ:PCSA ) ,20240119T152458,https://www.benzinga.com/news/24/01/36696774/why-processa-pharmaceuticals-pcsa-stock-is-skyrocketing,PCSA,0.613172,Neutral,0.112519
"US Stocks Higher; Schlumberger Earnings Beat Estimates - Accelerate Diagnostics  ( NASDAQ:AXDX ) , C3is  ( NASDAQ:CISS ) ",20240119T145335,https://www.benzinga.com/news/earnings/24/01/36696062/us-stocks-higher-schlumberger-earnings-beat-estimates,PCSA,0.214304,Neutral,0.014607
Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer,20240119T124500,https://www.globenewswire.com/news-release/2024/01/19/2812259/0/en/Processa-Pharmaceuticals-Announces-Expansion-of-NGC-Cap-Program-into-Advanced-or-Metastatic-Breast-Cancer.html,PCSA,0.112885,Neutral,0.011693
"Dow Surges Over 100 Points; M&T Bank Posts Weak Earnings - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ",20240118T192554,https://www.benzinga.com/news/earnings/24/01/36684186/dow-surges-over-100-points-m-t-bank-posts-weak-earnings,PCSA,0.186738,Neutral,0.015613
"Crude Oil Rises Over 1%; Processa Pharmaceuticals Shares Slide - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ",20240118T170019,https://www.benzinga.com/news/earnings/24/01/36681909/crude-oil-rises-over-1-processa-pharmaceuticals-shares-slide,PCSA,0.210579,Neutral,0.01711
Why Processa Pharmaceuticals  ( PCSA )  Shares Are Nosediving - Processa Pharma  ( NASDAQ:PCSA ) ,20240118T155800,https://www.benzinga.com/news/24/01/36680527/why-processa-pharmaceuticals-pcsa-shares-are-nosediving,PCSA,0.757528,Somewhat-Bearish,-0.166268
"Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000 - Agrify  ( NASDAQ:AGFY ) , Aravive  ( NASDAQ:ARAV ) ",20240118T144720,https://www.benzinga.com/news/earnings/24/01/36679077/nasdaq-jumps-over-100-points-us-jobless-claims-fall-to-187-000,PCSA,0.236588,Neutral,0.018756
Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split,20240118T124500,https://www.globenewswire.com/news-release/2024/01/18/2811452/0/en/Processa-Pharmaceuticals-to-Effect-a-1-for-20-Reverse-Stock-Split.html,PCSA,0.154703,Neutral,-0.00407
Processa Pharmaceuticals to Present at the Biotech Showcase 2024,20240102T220600,https://www.globenewswire.com/news-release/2024/01/02/2802968/0/en/Processa-Pharmaceuticals-to-Present-at-the-Biotech-Showcase-2024.html,PCSA,0.218161,Neutral,-0.017346
"Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Advent Technologies Hldgs  ( NASDAQ:ADN ) , Asset Entities  ( NASDAQ:ASST ) ",20231222T125831,https://www.benzinga.com/news/23/12/36360331/why-rocket-lab-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket,PCSA,0.190667,Neutral,0.140025
Processa Pharmaceuticals Innovative Cancer Treatment Demonstrates Higher Efficacy at Lower Doses Over Capecitabine - Processa Pharma  ( NASDAQ:PCSA ) ,20231219T204118,https://www.benzinga.com/general/biotech/23/12/36311191/processa-pharmaceuticals-innovative-cancer-treatment-demonstrates-higher-efficacy-at-lower-doses-,PCSA,0.350564,Somewhat-Bullish,0.163882
Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine,20231219T140000,https://www.globenewswire.com/news-release/2023/12/19/2798574/0/en/Processa-Pharmaceuticals-Provides-Interim-Analysis-from-Ongoing-Phase-1b-Trial-of-Next-Generation-Capecitabine-Showing-Improved-Safety-Over-Capecitabine.html,PCSA,0.092095,Neutral,0.008534
"Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ",20231213T193056,https://www.benzinga.com/news/earnings/23/12/36223562/dow-jumps-over-200-points-federal-reserve-holds-interest-rates-steady,PCSA,0.132733,Somewhat-Bearish,-0.20352
"Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ",20231213T170550,https://www.benzinga.com/news/earnings/23/12/36220335/crude-oil-gains-1-5-blackboxstocks-shares-plummet,PCSA,0.141726,Somewhat-Bearish,-0.210589
What's Going On With Processa Pharmaceuticals  ( PCSA )  Stock? - Processa Pharma  ( NASDAQ:PCSA ) ,20231213T144255,https://www.benzinga.com/news/23/12/36216822/whats-going-on-with-processa-pharmaceuticals-pcsa-stock,PCSA,0.727604,Somewhat-Bearish,-0.278045
"US Stocks Mixed; Producer Prices Unchanged For November - Blackboxstocks  ( NASDAQ:BLBX ) , C4 Therapeutics  ( NASDAQ:CCCC ) ",20231213T144014,https://www.benzinga.com/news/earnings/23/12/36216825/us-stocks-mixed-producer-prices-unchanged-for-november,PCSA,0.146469,Neutral,-0.099483
Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine,20231213T140000,https://www.globenewswire.com/news-release/2023/12/13/2795618/0/en/Processa-Pharmaceuticals-Announces-Successful-Phase-2-Meeting-with-FDA-for-Next-Generation-Capecitabine.html,PCSA,0.13637,Neutral,0.002555
"Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket - African Agriculture Hldgs  ( NASDAQ:AAGR ) , AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) ",20231211T125928,https://www.benzinga.com/news/23/12/36174622/why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket,PCSA,0.14131,Neutral,0.043971
"Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook",20231129T131500,https://www.globenewswire.com/news-release/2023/11/29/2787726/0/en/Processa-Pharmaceuticals-Issues-Letter-to-Shareholders-Highlighting-Corporate-Strategy-Drug-Pipeline-and-Outlook.html,PCSA,0.071428,Neutral,-0.012226
"Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket - Anghami  ( NASDAQ:ANGH ) , AgileThought  ( NASDAQ:AGIL ) ",20231122T125806,https://www.benzinga.com/news/23/11/35914672/why-guess-shares-are-trading-lower-by-around-15-here-are-20-stocks-moving-premarket,PCSA,0.13459,Bearish,-0.421318
"Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson",20231113T184000,https://www.globenewswire.com/news-release/2023/11/13/2779363/0/en/Processa-Pharmaceuticals-Inc-Mourns-the-Sudden-Passing-of-Board-Member-Virgil-Thompson.html,PCSA,0.177802,Neutral,-0.017685
Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas,20231109T131500,https://www.globenewswire.com/news-release/2023/11/09/2777341/0/en/Processa-Pharmaceuticals-to-Present-at-the-20th-Orphan-Drugs-and-Rare-Diseases-Global-Congress-2023-Americas.html,PCSA,0.233556,Neutral,-0.0423
Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders,20231101T121500,https://www.globenewswire.com/news-release/2023/11/01/2771155/0/en/Processa-Pharmaceuticals-Announces-Formation-of-Oncology-Advisory-Board-with-Renowned-Key-Opinion-Leaders.html,PCSA,0.085527,Neutral,-0.01155
Global Gastroparesis Treatment Market is Expected to Grow Revenue up to USD 11.09 Billion By 2030 with a Growing CAGR of 3.3% | Infinium Global Research,20231027T093000,https://www.prnewswire.com/news-releases/global-gastroparesis-treatment-market-is-expected-to-grow-revenue-up-to-usd-11-09-billion-by-2030-with-a-growing-cagr-of-3-3--infinium-global-research-301969986.html,PCSA,0.041682,Neutral,-0.084698
"Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket - Aravive  ( NASDAQ:ARAV ) , American Well  ( NYSE:AMWL ) ",20231020T114219,https://www.benzinga.com/news/23/10/35347610/why-knight-swift-transportation-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-pre,PCSA,0.129866,Neutral,-0.077973
"Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Akso Health Group  ( NASDAQ:AHG ) , AGBA Group Holding  ( NASDAQ:AGBA ) ",20231017T121251,https://www.benzinga.com/news/23/10/35284666/why-vistagen-therapeutics-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket,PCSA,0.152499,Neutral,-0.060975
"Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Aldeyra Therapeutics  ( NASDAQ:ALDX ) , Alignment Healthcare  ( NASDAQ:ALHC ) ",20231016T170953,https://www.benzinga.com/news/23/10/35272489/why-streamline-health-solutions-shares-are-trading-lower-by-over-68-here-are-other-stocks-moving-in,PCSA,0.076236,Somewhat-Bullish,0.169195
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket,20231016T131535,https://markets.businessinsider.com/news/stocks/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket-1032708380,PCSA,0.105604,Somewhat-Bullish,0.157008
"Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amphenol  ( NYSE:APH ) ",20231016T124712,https://www.benzinga.com/news/23/10/35266067/why-contrafect-shares-are-trading-higher-by-around-30-here-are-20-stocks-moving-premarket,PCSA,0.194242,Somewhat-Bullish,0.205479
"Top 3 Health Care Stocks That May Implode This Quarter - Acurx Pharmaceuticals  ( NASDAQ:ACXP ) , Cardinal Health  ( NYSE:CAH ) ",20231016T122829,https://www.benzinga.com/news/23/10/35265545/top-3-health-care-stocks-that-may-implode-this-quarter,PCSA,0.345674,Somewhat-Bullish,0.338
Processa Pharmaceuticals to Present at the ThinkEquity Conference,20231013T170800,https://www.globenewswire.com/news-release/2023/10/13/2760110/0/en/Processa-Pharmaceuticals-to-Present-at-the-ThinkEquity-Conference.html,PCSA,0.231332,Neutral,-0.018196
"Why Rubicon Technologies Shares Are Trading Lower By Over 7%; Here Are 20 Stocks Moving Premarket - AgriFORCE Growing Systems  ( NASDAQ:AGRI ) , Astra Space  ( NASDAQ:ASTR ) ",20230918T121035,https://www.benzinga.com/news/23/09/34686199/why-rubicon-technologies-shares-are-trading-lower-by-over-7-here-are-20-stocks-moving-premarket,PCSA,0.198221,Neutral,-0.073399
Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference,20230906T121500,https://www.globenewswire.com/news-release/2023/09/06/2738375/0/en/Processa-Pharmaceuticals-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html,PCSA,0.226301,Neutral,-0.017826
"Why Dell Technologies Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Acer Therapeutics  ( NASDAQ:ACER ) , Aditxt  ( NASDAQ:ADTX ) ",20230901T121610,https://www.benzinga.com/news/23/09/34169746/why-dell-technologies-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket,PCSA,0.146469,Neutral,0.047755
Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care,20230817T120500,https://www.globenewswire.com/news-release/2023/08/17/2727217/0/en/Processa-Pharmaceuticals-Provides-Data-Update-Supporting-a-Potential-Personalized-Treatment-Approach-for-Improved-Cancer-Care.html,PCSA,0.09186,Neutral,0.005386
Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference,20230810T201500,https://www.globenewswire.com/news-release/2023/08/10/2723192/0/en/Processa-Pharmaceuticals-to-Present-at-the-Sidoti-Co-Micro-Cap-Virtual-Conference.html,PCSA,0.229149,Neutral,-0.019858
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,PCSA,0.02074,Neutral,-0.062117
"Why MicroVision Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket - Bone Biologics  ( NASDAQ:BBLG ) , Applied UV  ( NASDAQ:AUVI ) ",20230615T120517,https://www.benzinga.com/news/23/06/32871563/why-microvision-shares-are-trading-higher-by-28-here-are-20-stocks-moving-premarket,PCSA,0.222157,Neutral,-0.139179
Next Generation Chemotherapy: Improved Treatment for More Patients,20230614T201500,https://www.globenewswire.com/news-release/2023/06/14/2688466/0/en/Next-Generation-Chemotherapy-Improved-Treatment-for-More-Patients.html,PCSA,0.212425,Neutral,-0.018748
Longeveron Welcomes Three New Prominent Board Members,20230613T123000,https://www.globenewswire.com/news-release/2023/06/13/2687120/0/en/Longeveron-Welcomes-Three-New-Prominent-Board-Members.html,PCSA,0.05749,Neutral,0.008996
"Over $1M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying - Grove Collaborative Hldgs  ( NYSE:GROV ) , Processa Pharma  ( NASDAQ:PCSA ) ",20230613T113419,https://www.benzinga.com/trading-ideas/long-ideas/23/06/32832117/over-1m-bet-on-this-tech-stock-check-out-these-3-penny-stocks-insiders-are-aggressively-,PCSA,0.428632,Bullish,0.411598
Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress,20230522T120500,https://www.globenewswire.com/news-release/2023/05/22/2673319/0/en/Processa-Pharmaceuticals-to-Participate-in-a-Panel-on-Interaction-with-the-FDA-at-the-World-Orphan-Drug-Congress.html,PCSA,0.242285,Neutral,0.003787
Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting,20230428T121500,https://www.globenewswire.com/news-release/2023/04/28/2657401/0/en/Processa-Pharmaceuticals-to-Present-PCS12852-Gastroparesis-Results-at-the-Digestive-Disease-Week-2023-Annual-Meeting.html,PCSA,0.209365,Neutral,0.042133
PCSA: Why Insiders Are Aggressively Buying This Under $1 Stock,20230418T190914,https://stocknews.com/news/pcsa-gild-otsky-alxn-why-insiders-are-aggressively-buying-this-under-1-stock/,PCSA,0.784902,Somewhat-Bullish,0.323802
"Chembio Diagnostics And 2 Other Stocks Under $1 Insiders Are Aggressively Buying - Chembio Diagnostics  ( NASDAQ:CEMI ) , Malachite Innovations  ( OTC:MLCT ) ",20230414T124906,https://www.benzinga.com/trading-ideas/long-ideas/23/04/31805407/chembio-diagnostics-and-2-other-stocks-under-1-insiders-are-aggressively-buying,PCSA,0.572601,Bullish,0.40076
Processa Pharmaceuticals Announces First Patient Dosed in the 300 mg Dose Group with Next Generation Chemotherapy-Capecitabine,20230317T123000,https://www.globenewswire.com/news-release/2023/03/17/2629471/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Dosed-in-the-300-mg-Dose-Group-with-Next-Generation-Chemotherapy-Capecitabine.html,PCSA,0.192183,Neutral,0.084553
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference,20230307T133000,https://www.globenewswire.com/news-release/2023/03/07/2622067/0/en/Processa-Pharmaceuticals-to-Present-at-the-Oppenheimer-33rd-Annual-Healthcare-Conference.html,PCSA,0.321673,Neutral,0.081009
"Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules",20230210T130000,https://www.globenewswire.com/news-release/2023/02/10/2605900/0/en/Processa-Pharmaceuticals-Inc-Announces-6-25-Million-Registered-Direct-Offering-Priced-at-the-Market-Under-Nasdaq-Rules.html,PCSA,0.182506,Neutral,0.121106
"Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.",20230104T133000,https://www.globenewswire.com/news-release/2023/01/04/2582922/0/en/Processa-Pharmaceuticals-To-Present-an-Update-on-Its-Future-Therapeutic-Focus-and-Strategy-at-the-Biotech-Showcase-on-January-11-2023.html,PCSA,0.434142,Neutral,-0.011577
Processa Pharma's Investigational Candidate Improves Gastroparesis-Associated Clinical Symptoms - Processa Pharma  ( NASDAQ:PCSA ) ,20221214T180510,https://www.benzinga.com/general/biotech/22/12/30077697/processa-pharmas-investigational-candidate-improves-gastroparesis-associated-clinical-symptoms,PCSA,0.498188,Neutral,0.015832
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial,20221214T133000,https://www.globenewswire.com/news-release/2022/12/14/2573681/0/en/Processa-Pharmaceuticals-Announces-PCS12852-Successfully-Improves-the-Clinical-Symptoms-Associated-with-Gastroparesis-in-Phase-2A-Trial.html,PCSA,0.089797,Neutral,0.063043
"Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST",20221102T123000,https://www.globenewswire.com/news-release/2022/11/02/2546524/0/en/Processa-Pharmaceuticals-to-Host-Conference-Call-to-Discuss-Third-Quarter-2022-Results-and-Provide-Drug-Development-Update-on-November-8-2022-at-4-30-p-m-EST.html,PCSA,0.369685,Neutral,0.041244
Processa Pharmaceuticals Provides Update on Enrollment Across all Clinical Programs,20220915T123000,https://www.globenewswire.com/news-release/2022/09/15/2516896/0/en/Processa-Pharmaceuticals-Provides-Update-on-Enrollment-Across-all-Clinical-Programs.html,PCSA,0.099752,Neutral,0.020594
"Processa Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 12-14, 2022",20220907T123000,https://www.globenewswire.com/news-release/2022/09/07/2511531/0/en/Processa-Pharmaceuticals-to-Present-at-H-C-Wainwright-22nd-Annual-Global-Investment-Conference-on-September-12-14-2022.html,PCSA,0.362505,Neutral,0.040705
Processa Pharmaceuticals Appoints Khoso Baluch and James Neal to its Board of Directors and Justin Yorke to Chairman of the Board,20220816T123000,https://www.globenewswire.com/news-release/2022/08/16/2499067/0/en/Processa-Pharmaceuticals-Appoints-Khoso-Baluch-and-James-Neal-to-its-Board-of-Directors-and-Justin-Yorke-to-Chairman-of-the-Board.html,PCSA,0.139804,Neutral,0.041049
"Processa Pharmaceuticals to Host Conference Call to Discuss Its Second Quarter 2022 Results and Provide 2nd Half Clinical Pipeline Update on August 11, 2022, at 4:30 p.m. EST",20220805T190000,https://www.globenewswire.com/news-release/2022/08/05/2493407/0/en/Processa-Pharmaceuticals-to-Host-Conference-Call-to-Discuss-Its-Second-Quarter-2022-Results-and-Provide-2nd-Half-Clinical-Pipeline-Update-on-August-11-2022-at-4-30-p-m-EST.html,PCSA,0.369685,Neutral,0.041244
Processa Pharmaceuticals Announces Launch of Website to Increase Awareness of Ulcerative Necrobiosis Lipoidica and to Inform Patients of the ongoing Phase 2B Study of PCS499,20220804T133000,https://www.globenewswire.com/news-release/2022/08/04/2492535/0/en/Processa-Pharmaceuticals-Announces-Launch-of-Website-to-Increase-Awareness-of-Ulcerative-Necrobiosis-Lipoidica-and-to-Inform-Patients-of-the-ongoing-Phase-2B-Study-of-PCS499.html,PCSA,0.252332,Neutral,0.096601
"Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022",20220712T123000,https://www.globenewswire.com/news-release/2022/07/12/2478070/0/en/Processa-Pharmaceuticals-to-Present-at-the-World-Orphan-Drug-Congress-USA-July-11-13-2022.html,PCSA,0.178021,Neutral,0.030743
Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update,20220512T202000,https://www.globenewswire.com/news-release/2022/05/12/2442527/0/en/Processa-Pharmaceuticals-Announces-First-Quarter-2022-Financial-Results-and-Provides-Corporate-Update.html,PCSA,0.154257,Neutral,-0.007273
99 Biggest Movers From Yesterday,20220512T082956,https://www.benzinga.com/news/22/05/27156577/99-biggest-movers-from-yesterday,PCSA,0.042462,Neutral,-0.02247
90 Biggest Movers From Yesterday,20220510T091132,https://www.benzinga.com/news/22/05/27100105/90-biggest-movers-from-yesterday,PCSA,0.050306,Neutral,0.000559
90 Biggest Movers From Yesterday,20220510T091132,https://markets.businessinsider.com/news/stocks/90-biggest-movers-from-yesterday-1031440764,PCSA,0.023017,Neutral,0.00185
Processa Pharmaceuticals Doses First Patient in Amended Phase 1B Protocol for PCS6422 Combined with Capecitabine  ( Next Generation Capecitabine ) ,20220420T123000,https://www.globenewswire.com/news-release/2022/04/20/2425479/0/en/Processa-Pharmaceuticals-Doses-First-Patient-in-Amended-Phase-1B-Protocol-for-PCS6422-Combined-with-Capecitabine-Next-Generation-Capecitabine.html,PCSA,0.131884,Neutral,-0.003003
Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis,20220405T123000,https://www.globenewswire.com/news-release/2022/04/05/2416670/0/en/Processa-Pharmaceuticals-Announces-First-Patient-Enrolled-in-the-PCS12852-Phase-2A-Trial-for-the-Treatment-of-Gastroparesis.html,PCSA,0.092694,Neutral,0.00427
Processa Pharmaceuticals To Host Conference Call to Discuss Fourth Quarter 2021 Results and Provide Drug Development Update on March 30 at 4:30 p.m. EST,20220323T123000,https://www.globenewswire.com/news-release/2022/03/23/2408539/0/en/Processa-Pharmaceuticals-To-Host-Conference-Call-to-Discuss-Fourth-Quarter-2021-Results-and-Provide-Drug-Development-Update-on-March-30-at-4-30-p-m-EST.html,PCSA,0.32478,Neutral,0.014746
